Our premier facilities are a cornerstone of Takara Bio's promise to deliver the highest-quality products and impeccable services. Our facilities include: 

• Center for Gene and Cell Processing (CGCP)—an award-winning manufacturing facility for gene and cell therapy products
• hES Cell Banks—a specialized facility for the manufacture of human embryonic stem cell line derivation and banking

Center for Gene and Cell Processing (CGCP)

Our core manufacturing facility, the CGCP located in Kusatsu, Shiga, was designed specifically for the safe and efficient manufacture of gene and cell therapy products. In 2016, the International Society for Pharmaceutical Engineering selected Takara Bio’s CGCP as the winner of its Facility of the Year Award (in the facility integration category). Its unique environment ensures product safety and was determined by the judges to be a practical, efficient model for future biopharmaceutical facilities.

Meets major GMP regulations

The CGCP was designed to meet major regulations like cGMP, PIC/s GMP, and EU GMP. It has received accreditation as a “foreign cell processor” to conduct specific processed-cell manufacturing. It has also received ISO 9001 certification.

One-stop manufacturing facility

The CGCP's innovative use of facility integration allows for the production of cell products, viral vectors, and recombinant proteins within the same facility. Each area has an independent airflow pipeline, material flow, VHP (vaporized hydrogen system) for decontamination, and personnel team. They are also equipped with independent QC laboratories and dedicated facilities for cell banking. Since the independent processing areas are all under one roof, the CGCP can operate with high efficiency and zero contamination, so you can depend on the products produced and services performed on-site.

Designed for efficiency, purity, and high-quality production

• Multiple manufacturing rooms enable the parallel manufacture of multiple items
• Warehouse, storage rooms, and testing areas are configured for efficiency
• Air locks, one-way passage systems, independent ventilation systems, and separated flow for operations and materials minimize the risk of contamination

hES Cell Banks

Takara Bio Europe AB operates a specialized facility in Göteborg, Sweden, for the manufacture of human embryonic stem (hES) cell banks according to guidelines for Good Manufacturing Practices. In 2018, the facility was granted a manufacturing license by the Medical Products Agency (the Swedish national authority) for clinical-grade human embryonic stem cell line derivation and banking.

Please submit inquiries using the form on the left. If you are on a mobile device, click on the hamburger icon ()on the top left of your screen, then scroll down to access the form.